Pages that link to "Q48540299"

The following pages link to Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease. (Q48540299):

Displaying 39 items.

• Concise review: new paradigms for Down syndrome research using induced pluripotent stem cells: tackling complex human genetic disease (Q22241147) (← links)
• Molecular markers of early Parkinson's disease based on gene expression in blood (Q24292810) (← links)
• The ubiquitin-proteasome system in spongiform degenerative disorders (Q28386906) (← links)
• Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease (Q28573057) (← links)
• Discovering transnosological molecular basis of human brain diseases using biclustering analysis of integrated gene expression data (Q30965644) (← links)
• Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology (Q33389138) (← links)
• SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease (Q33531733) (← links)
• Single-cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene (Q33666819) (← links)
• Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death. (Q33889585) (← links)
• NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease (Q33958143) (← links)
• Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease (Q34032608) (← links)
• Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease (Q35290033) (← links)
• MicroRNA-mRNA regulatory networking fine-tunes the porcine muscle fiber type, muscular mitochondrial respiratory and metabolic enzyme activities (Q36093412) (← links)
• Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression. (Q36128123) (← links)
• A novel fumarate hydratase-deficient HLRCC kidney cancer cell line, UOK268: a model of the Warburg effect in cancer (Q36153426) (← links)
• Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation (Q36453886) (← links)
• Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases (Q36460964) (← links)
• A micro-silicon chip for in vivo cerebral imprint in monkey (Q36709100) (← links)
• Calcium, ageing, and neuronal vulnerability in Parkinson's disease (Q36947731) (← links)
• Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD. (Q37082018) (← links)
• Target identification for CNS diseases by transcriptional profiling. (Q37175279) (← links)
• Decreased parvalbumin mRNA expression in dorsolateral prefrontal cortex in Parkinson's disease. (Q37276021) (← links)
• Mitochondrial gene profiling: translational perspectives (Q37618225) (← links)
• Molecular Chaperones and Associated Cellular Clearance Mechanisms against Toxic Protein Conformers in Parkinson’s Disease (Q37853789) (← links)
• Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits. (Q37999105) (← links)
• Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis (Q38021940) (← links)
• Gene expression profiling in human neurodegenerative disease (Q38034387) (← links)
• Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies (Q38550428) (← links)
• Assessment of the direct and indirect effects of MPP and dopamine on the human proteasome: implications for Parkinson's disease aetiology. (Q40049783) (← links)
• Neuronal pentraxin II is highly upregulated in Parkinson's disease and a novel component of Lewy bodies (Q41847718) (← links)
• A unifying hypothesis for familial and sporadic Alzheimer's disease (Q42147254) (← links)
• A review of genome-wide transcriptomics studies in Parkinson's disease (Q42778276) (← links)
• Gene expression profiles of mouse striatum in control and maneb paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts (Q46666414) (← links)
• Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway (Q47099182) (← links)
• Manganese- and 1-methyl-4-phenylpyridinium-induced neurotoxicity display differences in morphological, electrophysiological and genome-wide alterations: implications for idiopathic Parkinson's disease (Q47648929) (← links)
• The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability. (Q48315546) (← links)
• The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor. (Q51764776) (← links)
• Up-regulation of metallothionein gene expression in parkinsonian astrocytes. (Q54356779) (← links)
• Common gene expression signatures in Parkinson's disease are driven by changes in cell composition (Q92127004) (← links)